Uracil Derivatives as AXL and C-MET Kinase Inhibitors

Uracil Derivatives as AXL and C-MET Kinase Inhibitors

The present invention provides compounds of Formula I or pharmaceutically acceptable salt forms thereof, wherein R a , R b , R c , R d , D, W, R 1a , R 1b , R 1c , Y, R 3 , X, E and G are as defined herein, and uses as AXL and c-MET kinase inhibitors .

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: Catherine P Prouty, Reddeppareddy Dandu, Rabindranath Tripathy, Robert L Hudkins, Kurt A Josef
Format: Patent
Sprache:eng
Online-Zugang:Volltext bestellen
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:The present invention provides compounds of Formula I or pharmaceutically acceptable salt forms thereof, wherein R a , R b , R c , R d , D, W, R 1a , R 1b , R 1c , Y, R 3 , X, E and G are as defined herein, and uses as AXL and c-MET kinase inhibitors .